PRIMROSE LANE PRACTICE — All Prescriptions & Medications — Page 5
Practice Code: M92004 | WOLVERHAMPTON, WV10 8RN
Showing results 201-250 of 375
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Bumetanide | 36 | 5,572 | £536 | -86.8% ▼ |
| 36 | 1,800 | £126 | -48.4% ▼ | |
| 36 | 1,740 | £2.3K | +120.6% ▲ | |
| Loratadine | 35 | 1,766 | £37 | -83.2% ▼ |
| Domperidone | 35 | 4,320 | £95 | -1.9% vs avg |
| Clarithromycin | 35 | 464 | £135 | -85.7% ▼ |
| Ferrous sulfate | 35 | 1,906 | £117 | -93.2% ▼ |
| Orlistat | 33 | 3,444 | £816 | -60.0% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 33 | 5,112 | £286 | -81.6% ▼ |
| Norethisterone | 33 | 1,334 | £224 | -32.0% ▼ |
| Dexamethasone | 33 | 225 | £61 | -44.7% ▼ |
| 33 | 2,000 | £1.4K | -0.2% vs avg | |
| Ticagrelor | 32 | 2,856 | £2.8K | -62.4% ▼ |
| Ropinirole hydrochloride | 32 | 3,024 | £1.9K | -69.9% ▼ |
| Erythromycin | 32 | 1,572 | £639 | -7.6% ▼ |
| Ready to serve 1.5 kcal/ml juice style (0913011) | 32 | 190.4K | £1.7K | -47.4% ▼ |
| Hepatitis A | 32 | 32 | £644 | -57.9% ▼ |
| 32 | 320 | £1.6K | +238.9% ▲ | |
| Nystatin | 31 | 930 | £53 | -69.2% ▼ |
| Terbutaline sulphate | 30 | 30 | £237 | -44.7% ▼ |
| Clomipramine hydrochloride | 30 | 2,352 | £451 | -28.8% ▼ |
| Chloramphenicol | 30 | 404 | £194 | -73.8% ▼ |
| Ciprofloxain/dexameth | 30 | 155 | £181 | -2.3% ▼ |
| Diphtheria | 30 | 30 | £215 | -55.0% ▼ |
| 30 | 6,400 | £2.2K | +507.8% ▲ | |
| Mebeverine hydrochloride | 29 | 2,676 | £76 | -90.7% ▼ |
| Colchicine | 29 | 1,980 | £37 | -62.8% ▼ |
| Latanoprost and timolol | 29 | 375 | £476 | -62.0% ▼ |
| 29 | 3,200 | £181 | -77.9% ▼ | |
| Rosuvastatin calcium | 28 | 1,568 | £53 | -96.9% ▼ |
| Aclidinium bromide/formoterol | 28 | 33 | £1.0K | -20.4% ▼ |
| Carmellose sodium | 28 | 3,060 | £460 | -56.8% ▼ |
| Benzydamine hydrochloride | 28 | 1,650 | £51 | -63.8% ▼ |
| Flecainide acetate | 27 | 2,052 | £85 | -65.4% ▼ |
| Tranexamic acid | 27 | 2,460 | £158 | -68.1% ▼ |
| Powder extensively hydrolysed formula (0913101) | 27 | 78.4K | £2.2K | -62.5% ▼ |
| Hypromellose | 27 | 460 | £108 | -79.6% ▼ |
| 27 | 280 | £766 | -43.5% ▼ | |
| 27 | 3,575 | £494 | +104.7% ▲ | |
| Mesalazine (Systemic) | 26 | 5,160 | £2.8K | -89.1% ▼ |
| Trimethoprim | 26 | 1,351 | £46 | -87.3% ▼ |
| Betamethasone esters | 26 | 2,230 | £231 | -56.9% ▼ |
| 26 | 260 | £33 | -30.9% ▼ | |
| 26 | 2,450 | £491 | +0.8% vs avg | |
| Dosulepin hydrochloride | 25 | 3,864 | £815 | -55.8% ▼ |
| Alfacalcidol | 25 | 2,550 | £395 | -79.8% ▼ |
| Bisacodyl | 24 | 1,640 | £82 | -81.7% ▼ |
| Haloperidol | 24 | 1,802 | £1.3K | -49.6% ▼ |
| Insulin Lispro | 24 | 175 | £1.0K | -68.6% ▼ |
| Insulin detemir | 24 | 215 | £1.8K | -69.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.